EUROAPI generates substantial annual financial turnover operating as an independent active pharmaceutical ingredient manufacturer, with its latest trailing twelve-month revenues scaling to approximately €852.6 million (roughly ₹95.8 billion INR equivalent). Financial disclosures illustrate steady industrial output, custom contract development and manufacturing organization services, and extensive global export deliveries spanning numerous international healthcare markets.